Insider · CIK 0001708062
Harry Skip Kiil
Files at MDT (Medtronic plc). First filing Sep 5, 2025, latest Sep 17, 2026.
Harry Skip Kiil files SEC Form 4 as officer at MDT (Medtronic plc). Since Sep 5, 2025, Harry Skip Kiil has reported 0 open-market buys worth $0 and 4 open-market sells worth $6.4M, the latest filed on Sep 17, 2026.
A track record needs three past buys with six months of prices behind them; Harry Skip Kiil has 0, so none is measured yet.
The newest scored trade: sold $139k of MDT on Sep 16, 2026, filed Sep 17, 2026, scored 26 (weak). In the last 12 months: 0 buys worth $0 and 3 sells worth $5.6M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDT: Medtronic plc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | MDTsell Medtronic plc | $139k 1,483 shares | -3% | - | |
| 35Weak | MDTsell Medtronic plc | $337k 4,189 shares | -10% | +9% from low-22% from high | |
| 45Moderate | MDTsell Medtronic plc | $5.1M 52,524 shares | -62% | +24% from low-7% from high | |
| 42Moderate | MDTsell Medtronic plc | $788k 8,605 shares | -19% | +18% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 8, 2026 | MDT Medtronic plc | 4,189 0.00% of outstanding | $337k | Jun 8, 2026 | none |
| Feb 19, 2026 | MDT Medtronic plc | 52,524 0.00% of outstanding | $5.1M | Feb 19, 2026 | none |
| Sep 3, 2025 | MDT Medtronic plc | 8,605 0.00% of outstanding | $788k | Sep 3, 2025 | none |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -1,483 | $93.65 | $139k | 42,186 | 26 d ago |
| Jun 8, 2026 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -3,961 | $80.44 | $319k | 37,455 | Jun 9, 2026 |
| Jun 8, 2026 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -228 | $80.45 | $18k | 37,227 | Jun 9, 2026 |
| Jun 4, 2026 | MDT Medtronic plc | FTax withholding Ordinary Shares | -6,817 | $83.32 | $568k | 41,416 | Jun 8, 2026 |
| May 26, 2026 | MDT Medtronic plc | MOption exercise Ordinary Shares | +15,195 | $0.00 | $0 | 48,233 | May 28, 2026 |
| May 26, 2026 | MDT Medtronic plc | MOption exercise Performance Share Unitderivative | -14,517 | $0.00 | $0 | 0 | May 28, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | MOption exercise Ordinary Shares | +30,568 | $93.08 | $2.8M | 64,984 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | MOption exercise Ordinary Shares | +19,923 | $87.76 | $1.7M | 84,907 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | MOption exercise Ordinary Shares | +385 | $80.00 | $31k | 85,292 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -1,648 | $97.86 | $161k | 83,644 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -30,568 | $97.66 | $3.0M | 53,076 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -19,255 | $97.77 | $1.9M | 33,821 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -668 | $97.83 | $65k | 33,153 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -385 | $97.82 | $38k | 32,768 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | MOption exercise Stock Option (Right to Buy)derivative | -30,568 | $0.00 | $0 | 11,606 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | MOption exercise Stock Option (Right to Buy)derivative | -19,923 | $0.00 | $0 | 18,926 | Feb 26, 2026 |
| Feb 19, 2026 | MDT Medtronic plc | MOption exercise Stock Option (Right to Buy)derivative | -385 | $0.00 | $0 | 1,155 | Feb 26, 2026 |
| Dec 5, 2025 | MDT Medtronic plc | FTax withholding Ordinary Shares | -1,702 | $101.36 | $173k | 34,177 | Dec 9, 2025 |
| Sep 3, 2025 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -8,405 | $91.58 | $770k | 35,815 | Sep 5, 2025 |
| Sep 3, 2025 | MDT Medtronic plc | SOpen-market sale Ordinary Shares | -200 | $91.59 | $18k | 35,615 | Sep 5, 2025 |
| Aug 1, 2025 | MDT Medtronic plc | MOption exercise Ordinary Shares | +10,457 | $0.00 | $0 | 51,775 | Aug 4, 2025 |
| Aug 1, 2025 | MDT Medtronic plc | FTax withholding Ordinary Shares | -4,659 | $89.34 | $416k | 47,116 | Aug 4, 2025 |
| Aug 1, 2025 | MDT Medtronic plc | FTax withholding Ordinary Shares | -2,896 | $89.34 | $259k | 44,220 | Aug 4, 2025 |
| Aug 1, 2025 | MDT Medtronic plc | MOption exercise Performance Share Unitderivative | -10,457 | $0.00 | $0 | 0 | Aug 4, 2025 |
| Jul 28, 2025 | MDT Medtronic plc | AGrant or award Ordinary Shares | +7,612 | $0.00 | $0 | 41,318 | Jul 30, 2025 |
| Jul 28, 2025 | MDT Medtronic plc | AGrant or award Performance Share Unitsderivative | +19,028 | $0.00 | $0 | 19,028 | Jul 30, 2025 |
| Jul 28, 2025 | MDT Medtronic plc | AGrant or award Stock Option (Right to Buy)derivative | +53,671 | $0.00 | $0 | 53,671 | Jul 30, 2025 |
Questions about Harry Skip Kiil
Answered from the filings on this page, as of the latest one.
Is Harry Skip Kiil buying or selling?
In the last 12 months Harry Skip Kiil reported 0 open-market buys worth $0 and 3 open-market sells worth $5.6M on SEC Form 4; the latest was sold $139k of MDT on Sep 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Harry Skip Kiil's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Harry Skip Kiil has 0.
Where does Harry Skip Kiil file Form 4?
Harry Skip Kiil has filed Form 4 at MDT (Medtronic plc) as EVP & President Cardiovascular. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.